China Pharma Holdings
CPHI
8 hedge funds and large institutions have $420K invested in China Pharma Holdings in 2015 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and closing their positions.
50% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 2
0% more funds holding
Funds holding: 8 → 8 (0)
0% less ownership
Funds ownership: 0.01% → 0.01% (-0%)
52% less capital invested
Capital invested by funds: $884K → $420K (-$464K)
Top Buyers
| 1 |
Citadel Advisors
Miami,
Florida
|
+$3.1K |
| 2 |
VKH
Virtu KCG Holdings
New York
|
+$1.65K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$387 |
Top Sellers
| 1 |
FWSM
First Wilshire Securities Management
Pasadena,
California
|
-$40.7K |
| 2 |
Renaissance Technologies
New York
|
-$1.26K |
CPHI Hedge Fund Activity: Q4 2015 in Review
8 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in China Pharma Holdings (CPHI) for Q4 2015, worth a combined $420K — down 52% from $884K a quarter earlier.
Fund positioning in CPHI was balanced in Q4 2015: 0 funds opened new positions, 0 closed out, 3 added to existing stakes and 2 trimmed.
The largest buyer was Citadel Advisors, adding an estimated $3.1K. The largest seller was First Wilshire Securities Management, cutting an estimated $40.7K.
- 8 institutional investors held China Pharma Holdings (CPHI) as of Q4 2015, unchanged from Q3 2015.
- Funds reported $420K of China Pharma Holdings stock for Q4 2015, down 52% quarter-over-quarter.
- 0 funds opened new China Pharma Holdings positions in Q4 2015 and 0 closed out.
- The largest China Pharma Holdings buyer in Q4 2015 was Citadel Advisors, an estimated $3.1K added.
- The largest China Pharma Holdings seller in Q4 2015 was First Wilshire Securities Management, an estimated $40.7K sold.
Based on aggregated 13F filings for Q4 2015.